Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes

被引:171
作者
Zhang, Leshuai W. [1 ]
Yu, William W. [2 ]
Colvin, Vicki L. [2 ]
Monteiro-Riviere, Nancy A. [1 ]
机构
[1] N Carolina State Univ, Ctr Chem Toxicol Res & Pharmacokinet, Raleigh, NC 27606 USA
[2] Rice Univ, Dept Chem, Houston, TX 77005 USA
关键词
quantum dot; nanoparticles; skin penetration; cytokines; keratinocytes; cellular uptake; inflammation; skin;
D O I
10.1016/j.taap.2007.12.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantum dots nanoparticles have novel optical properties for biomedical applications and electronics, but little is known about their skin permeability and interaction with cells. QD621 are nail-shaped nanoparticles that contain a cadmium/selenide core with a cadmium sulfide shell coated with polyethylene glycol (PEG) and are soluble in water. QD were topically applied to porcine skin flow-through diffusion cells to assess penetration at 1 mu M, 2 mu M and 10 mu M for 24 h. QD were also studied in human epidermal keratinocytes (HEK) to determine cellular uptake, cyrotoxicity and inflammatory potential. Confocal microscopy depicted the penetration of QD621 through the uppermost stratum corneum (SC) layers of the epidermis and fluorescence was found primarily in the SC and near hair follicles. QD were found in the intercellular lipid bilayers of the SC by transmission electron microscopy (TEM). Inductively coupled plasma-optical emission spectroscopy (ICP-OES) analysis for cadmium (Cd) and fluorescence for QD both did not detect Cd nor fluorescence signal in the perfusate at any time point or concentration. In HEK, viability decreased significantly (p < 0.05) from 1.25 nM to 10nM after 24 b and 48 It. There was a significant increase in IL-6 at 1.25 nM to 10 nM, while IL-8 increased from 2.5nM to 10nM after 24 h and 48 h. TEM of HEK treated with 10 nM of QD621 at 24 h depicted QD in cytoplasmic vacuoles and at the periphery of the cell membranes. These results indicate that porcine skin penetration of QD621 is minimal and limited primarily to the outer SC layers, yet if the skin were damaged allowing direct QD exposure to skin or keratinocytes, an inflammatory response could be initiated. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:200 / 211
页数:12
相关论文
共 72 条
[1]   Cytokine induction as a measure of cutaneous toxicity in primary and immortalized porcine keratinocytes exposed to jet fuels, and their relationship to normal human epidermal keratinocytes [J].
Allen, DG ;
Riviere, JE ;
Monteiro-Riviere, NA .
TOXICOLOGY LETTERS, 2001, 119 (03) :209-217
[2]  
Allen DG, 2000, J BIOCHEM MOL TOXIC, V14, P231, DOI 10.1002/1099-0461(2000)14:5<231::AID-JBT1>3.0.CO
[3]  
2-K
[4]   Analysis of interleukin-8 release from normal human epidermal keratinocytes exposed to aliphatic hydrocarbons:: delivery of hydrocarbons to cell cultures via complexation with α-cyclodextrin [J].
Allen, DG ;
Riviere, JE ;
Monteiro-Riviere, NA .
TOXICOLOGY IN VITRO, 2001, 15 (06) :663-669
[5]   Skin penetration and distribution of polymeric nanoparticles [J].
Alvarez-Román, R ;
Naik, A ;
Kalia, Y ;
Guy, RH ;
Fessi, H .
JOURNAL OF CONTROLLED RELEASE, 2004, 99 (01) :53-62
[6]   Noninvasive imaging of quantum dots in mice [J].
Ballou, B ;
Lagerholm, BC ;
Ernst, LA ;
Bruchez, MP ;
Waggoner, AS .
BIOCONJUGATE CHEMISTRY, 2004, 15 (01) :79-86
[7]  
BARKER JNWN, 1991, J IMMUNOL, V146, P1192
[8]   Penetration of metallic nanoparticles in human full-thickness skin [J].
Baroli, Biancamaria ;
Ennas, Maria Grazia ;
Loffredo, Felice ;
Isola, Michela ;
Pinna, Raimondo ;
Arturo Lopez-Quintela, M. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) :1701-1712
[9]   Surface modification to reduce nonspecific binding of quantum dots in live cell assays [J].
Bentzen, EL ;
Tomlinson, ID ;
Mason, J ;
Gresch, P ;
Warnement, MR ;
Wright, D ;
Sanders-Bush, E ;
Blakely, R ;
Rosenthal, SJ .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1488-1494
[10]   METHODS FOR INVITRO PERCUTANEOUS-ABSORPTION STUDIES .4. THE FLOW-THROUGH DIFFUSION CELL [J].
BRONAUGH, RL ;
STEWART, RF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (01) :64-67